| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $31,030,433 ) (Continued on the next page) |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EY021784 | Paradigms of maintaining anterior segment homeostasis | 000 | 14 | NIH | 4/11/2025 | $572,513 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 003 | 7 | NIH | 6/6/2025 | $32,048 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 001 | 7 | NIH | 1/23/2025 | $27,852 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 000 | 7 | NIH | 1/17/2025 | $288,417 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA236857 | Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer | 002 | 7 | NIH | 1/24/2025 | $13,539 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AG091424 | The Role of Alzheimer's Disease Risk Genes in Neural Function, Degeneration, and Synapse Organization | 000 | 1 | NIH | 1/15/2025 | $429,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156956 | Elucidating the mechanisms underlying DNA double-strand break repair | 000 | 1 | NIH | 1/23/2025 | $390,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HD112076 | Dose based aspirin pharmacokinetics and pharmacodynamics in pregnancy and association with pregnancy outcomes | 000 | 1 | NIH | 1/13/2025 | $678,809 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R37CA234239 | Tumor Microenvironment Metabolism in Invasive Ductal Carcinoma of the Breast | 002 | 6 | NIH | 4/21/2025 | $29,073 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 003 | 5 | NIH | 6/12/2025 | -$44,845 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 001 | 5 | NIH | 4/10/2025 | -$245,704 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA244522 | Tissue Damage-Driven Squamous Cell Carcinoma | 000 | 5 | NIH | 1/1/2025 | $321,165 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 001 | 4 | NIH | 6/11/2025 | $54,001 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA268899 | A novel strategy for transcriptional reprogramming of lymphoid leukemia cells | 000 | 4 | NIH | 1/9/2025 | $486,021 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI156384 | Role of IL-7R in CNS autoimmunity | 000 | 4 | NIH | 11/26/2024 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R33HL173910 | RNA-based therapeutics for hemostasis and thrombosis | 000 | 2 | NIH | 4/15/2025 | $491,398 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR082460 | The role of endogenous low molecular weight mineralization inhibitors in spine health | 000 | 2 | NIH | 11/13/2024 | $599,407 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01HL173436 | Platelets as regulator of non-neurological complications of ischemic stroke | 000 | 1 | NIH | 6/12/2025 | $779,952 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AG078609 | ASK1 inhibition as a novel strategy to regulate immune function and promote regeneration | 000 | 3 | NIH | 1/17/2025 | $646,492 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS121143 | Developing RNA Oligonucleotides to Mitigate Abberant FUS Phase Transition in FTD/ALS | 000 | 3 | NIH | 4/4/2025 | $351,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK136992 | Hypercalciuria and Abnormal Bone in the Genetic Hypercalciuric Stone-Forming Rats | 000 | 2 | NIH | 3/27/2025 | $410,872 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS132056 | Mitochondrial Calcium and Neuronal Health | 000 | 3 | NIH | 5/30/2025 | $623,535 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01ES034077 | The Role of m6A-RNA Methylation in Memory Formation and Recall and Its Modulation and Influence on Long-Term Outcomes as a Consequence of Early Life Lead Exposure | 000 | 3 | NIH | 4/15/2025 | $549,132 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA267549 | WNT pathway-driven anti-estrogen therapy resistance in breast cancer | 001 | 3 | NIH | 5/22/2025 | $54,969 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA267549 | WNT pathway-driven anti-estrogen therapy resistance in breast cancer | 000 | 3 | NIH | 4/14/2025 | $494,727 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM147191 | From mtDNA stress to cellular immunity: Triggers, Mechanisms and Effectors | 000 | 4 | NIH | 4/8/2025 | $390,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 001 | 4 | NIH | 5/22/2025 | $64,481 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA263506 | MiR-152/PKM2/SLC7A5 axis in breast cancer development, chemo- and radiation-treatment response | 000 | 4 | NIH | 3/27/2025 | $580,329 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA262570 | Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer | 003 | 4 | NIH | 5/22/2025 | $59,717 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA262570 | Pharmacological Jak2 inhibition to overcome androgen receptor aberrations in prostate cancer | 002 | 4 | NIH | 3/19/2025 | $537,456 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21NS142744 | Somatic instability of CAG repeats in spinal and bulbar muscular atrophy | 000 | 1 | NIH | 5/14/2025 | $429,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32HD117733 | Clinical Pharmacology Training Program | 001 | 1 | NIH | 6/3/2025 | $3,315 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | T32HD117733 | Clinical Pharmacology Training Program | 000 | 1 | NIH | 5/21/2025 | $208,150 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA256945 | Mechanisms of cell death in cutaneous melanoma | 000 | 5 | NIH | 4/23/2025 | $430,039 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA256945 | Mechanisms of cell death in cutaneous melanoma | 001 | 5 | NIH | 6/4/2025 | $47,783 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI160189 | IL-37: a novel regulator of inflammation in CNS autoimmunity | 000 | 4 | NIH | 4/23/2025 | $390,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AR078440 | Caspase-1 Activation by the Inflammasomes | 000 | 5 | NIH | 4/30/2025 | $549,226 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01CA255792 | Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer | 000 | 5 | NIH | 6/12/2025 | $653,812 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI162971 | IRF7-mediated development of autoreactive B cells and SLE | 002 | 5 | NIH | 5/21/2025 | $543,950 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01AI152251 | Oligodendrocyte extracellular vesicles: a novel therapy for CNS autoimmunity | 000 | 5 | NIH | 2/13/2025 | $378,300 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01EB032333 | Monodisperse Microbubbles for Noninvasive Pressure Estimation | 001 | 4 | NIH | 5/22/2025 | $600,307 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 001 | 5 | NIH | 5/14/2025 | $47,718 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK125897 | ER-mitochondrial communication in calcium signaling, energy metabolism and liver disease | 000 | 5 | NIH | 2/20/2025 | $429,469 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138011 | Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction | 001 | 2 | NIH | 6/12/2025 | $52,568 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01DK138011 | Relevance of fatty acid handling in the adaptive response to mitochondrial dysfunction | 000 | 2 | NIH | 2/17/2025 | $473,105 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21NS135762 | Molecular pathways linking frontotemporal dementia and circadian dysfunction | 000 | 2 | NIH | 2/14/2025 | $195,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R35GM156496 | Biogenesis and function of cyclic phosphate-containing RNAs | 000 | 1 | NIH | 2/3/2025 | $429,000 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R21AI190614 | The Role of the GPR15-C10ORF99 Pathway in T cell Homing during Eosinophilic Esophagitis | 000 | 1 | NIH | 2/1/2025 | $226,980 |
| | 2025 | 2025 | THOMAS JEFFERSON UNIVERSITY | 1020 WALNUT ST STE 1 | PHILADELPHIA | PA | 19107-5567 | PHILADELPHIA | USA | R01NS134987 | Neuroimaging and Connectome Analysis as a Diagnostic and Prognostic Biomarker of SCI Induced Neuropathic Pain | 000 | 2 | NIH | 4/14/2025 | $564,509 |
|
